Découvrez les Meilleures Cliniques et Coûts pour Votre Immunohistochimie en Israël en 2026

Le Dr Ofer Merimsly est le meilleur médecin spécialiste du sarcome, du lymphome et du cancer du poumon en Israël et dans le monde. Il est également spécialisé dans le traitement chirurgical de Whipple pour les patients atteints de cancer du pancréas. Chef du Centre national des sarcomes des os et des tissus mous du Centre médical de Tel Aviv Sourasky (Ichilov).

Spécialité:

• Traitement de tous les types de cancer du poumon et des organes thoraciques
• Traitement de tous les types de sarcomes des os et des tissus mous
• Traitement des tumeurs stromales du tractus gastro-intestinal

Éducation et spécialisation :

• Enseignement médical supérieur, diplômé de la faculté de médecine de l'université hébraïque de Jérusalem, Israël
• Résidence en oncologie générale et radiothérapie
• Formation dans le domaine de la radiothérapie et de la curiethérapie au New York Hospital, USA
• Cours de perfectionnement spécial pour le traitement des tumeurs du squelette et des tissus mous, Paris. France

Membres:

• Président de la Société des oncologues et radiothérapeutes d'Israël
• La Société scientifique américaine du cancer
• Organisation médicale scientifique européenne
• Société européenne d'oncologie du système musculo-squelettique
• Société internationale pour le traitement des tumeurs du tissu conjonctif

.

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Dr. Gal Goldstein is a leading specialist in Pediatric Oncology and Hemato-Oncology at Hadassah Medical Center. He is the Head of the Pediatric Oncology and Hemato-Oncology Department at Hadassah Hospital Ein Kerem.

Dr. Goldstein has over 20 years of experience. He focuses on retinoblastoma, precision medicine, and haploidentical bone marrow transplantation. He graduated from Tel Aviv University. In 2019-2020, Forbes named him one of the best doctors in Israel.

Dr. Goldstein is a member of The Israel Society of Pediatric Hematology and Oncology, The Israeli Cancer Association, and The International Society of Pediatric Oncology. He is dedicated to advancing pediatric cancer care.

Professor Dina Ben-Yehuda is a leading oncohematologist in Israel. She directs the Hematology Department at Hadassah Medical Center. She founded the laboratory for molecular diagnostics of blood diseases. She is known for her research in malignant blood diseases, bone marrow transplantation, gene therapy, and immunology.

Prof. Ben-Yehuda completed her postgraduate training at Memorial Sloan-Kettering Cancer Center. She has led Hadassah’s hematology department since 2000. In 2017, she became the first woman to serve as Dean of the Hadassah School of Medicine. She has received the Danielle Sonnenfeld Foundation’s Healing with the Heart Award. She is also a member of several national and international hematology societies.